Last $197.39 USD
Change Today -1.99 / -1.00%
Volume 1.5M
ACT On Other Exchanges
Symbol
Exchange
Berlin
New York
As of 8:04 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Paul M. Bisaro

Chairman, Chief Executive Officer and President, Actavis plc
AgeTotal Calculated CompensationThis person is connected to 38 board members in 5 different organizations across 9 different industries.

See Board Relationships
52$11,381,072
As of Fiscal Year 2013

Background*

Mr. Paul M. Bisaro has been the Chairman, Chief Executive Officer and President at Actavis Limited since October 2013. Mr. Bisaro has been the Chairman and Chief Executive Officer of Actavis plc since October 2, 2013 and September 4, 2007 respectively. He has been the President of Actavis plc since September 4, 2007. He served as the President and Chief Operating Officer of Barr Pharmaceuticals Inc. from December 1999 to August 2007. He joined the Barr Pharmaceuticals ...

Read Full Background

Corporate Headquarters*

Morris Corporate Center III
Parsippany, New Jersey 07054

United States

Phone: 862-261-7000
Fax: --

Board Members Memberships*

Independent Director
Director
1998-N/A
Former President, Chief Operating Officer, Director, President of New BLI and Chief Operating Officer of New BLI
2007-Present
Chairman, Chief Executive Officer and President
2013-Present
Independent Director, Member of Compensation & Management Development Committee and Member of Corporate Governance Committee
2013-Present
Chairman, Chief Executive Officer and President

Education*

Bachelor's Degree 1983
University of Michigan
JD 1989
Catholic University of America

Other Affiliations*

Annual Compensation*

Salary$1,276,923
Bonus$1,318,750
Total Annual Compensation$2,595,673

Stock Options*

Restricted Stock Awards$6,011,652
All Other Compensation$92,497
Exercised Options Value$55,234,744
Total Value of Options$55,234,744

Total Compensation*

Total Annual Cash Compensation$5,369,420
Total Short Term Compensation$2,595,673
Other Long Term Compensation$6,104,149
Total Calculated Compensation$11,381,072
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACT:US $197.39 USD -1.99

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
David E. I. Pyott Chairman and Chief Executive Officer
Allergan Inc.
$1.4M
J. Michael Pearson Chairman and Chief Executive Officer
Valeant Pharmaceuticals International, Inc.
$1.7M
Flemming Ornskov M.D., MBA, MPHChief Executive Officer and Director
Shire plc
$2.7M
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
--
José E. Almeida Chairman, Chief Executive Officer and President
Covidien plc
$1.2M
Compensation as of Fiscal Year 2013.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACTAVIS PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.